RxDoctor Payments Data

Gregory Montoya, MD

Psychiatry · Texarkana, TXNPI 1083614176

Payments from drug & device makers

$9,377in general payments, 2019–2025

Across 626 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$1K
  • Vanda Pharmaceuticals Inc.$1K
  • Neurocrine Biosciences, Inc.$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Alkermes, Inc.$1K
  • AbbVie$1K
  • plus $2K from 13 others

What the payments were for

  • Food & beverage$9,372100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,377 in reported general payments places this provider in the 90th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$3,550
Medicare patients
26
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate15$127,240
Invega SustennaPaliperidone Palmitate20$63,912
VraylarCariprazine Hcl12$19,335
TrintellixVortioxetine Hydrobromide12$6,058
Aripiprazole83$4,959
Ziprasidone Hcl48$3,980
Divalproex Sodium47$2,189
Divalproex Sodium ErDivalproex Sodium26$1,626
Olanzapine40$1,156
Fluoxetine Hcl92$1,126
Quetiapine Fumarate ErQuetiapine Fumarate23$1,045
Clonazepam92$1,039
Buspirone Hcl66$921
Oxcarbazepine12$781
Benztropine Mesylate44$696

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$1,174$127,24015 claims
Johnson & JohnsonInvega Sustenna$361$63,91220 claims
AbbVieVraylar$1,006$19,33512 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$14$6,05812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Texarkana

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →